ARCHIVES

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008